Skip to main content
The current Janssen COVID-19 Vaccine supply has the frozen (-25°C to -15°C) vaccine expiry date (EXP) printed on the carton and vial label. Once thawed, the vaccine can be stored and transported at 2°C to 8°C for a single period of up to 6 months, not exceeding the original expiry date.  DO NOT RE-FREEZE ONCE THAWED.

Janssen

 

homepage-background

JANSSEN MEDICAL INFORMATION

Monday-Friday (8:30AM - 4:30PM ET)

Toll Free 1-800-567-3331

Reminder to Please Call us...

  • To report a possible adverse event or product quality complaint
  • If you have an urgent question on one of the products from Janssen

JANSSEN MEDICAL INFORMATION

Monday-Friday (8:30AM - 4:30PM EST)

Toll Free: 1-800-567-3331

  • To report a possible Janssen COVID-19 Vaccine adverse event or product quality complaint, please call:

JANSSEN COVID-19 VACCINE CONTACT CENTRE

Daily

Toll Free: 1-800-565-4008

US Toll: 1-908-455-9922

Continue

Janssen COVID-19 Vaccine

You are about to review information on the Janssen COVID-19 Vaccine. Please select the following that would apply to you:

I am a Healthcare Professional in Canada I am a consumer or caregiver in Canada I am a US Healthcare Professional I am a US consumer or caregiver

  • Home
  • COVID-19 Vaccine
  • Product Monographs
  • Submit a Question
  • Compassionate Use
  • Login
  • Register
  • English
  • Français

Janssen COVID-19 Vaccine

  • The Janssen COVID-19 Vaccine is indicated for active immunization to prevent coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in individuals 18 years of age and older. The Janssen COVID-19 Vaccine must be injected intramuscularly only. Drug Identification Number (DIN): 02513153.

  • Vaccine Access
  • Medical Information Responses
  • COVID-19 Vaccine Clinical Trials
  • General Information on COVID-19 Vaccines
  • Johnson & Johnson Press Releases
  • National Advisory Committee on Immunization (NACI) Recommendations
  • Cannot find what you are looking for?
  • Janssen COVID-19 Vaccine Medication Information
    Janssen COVID-19 Vaccine Medication Information

    For more information, please download:

    PDF icon Product Monograph (PDF) March 24, 2022
    PDF icon Patient Medication Information (PDF) March 24, 2022
    PDF icon Health Product Risk Communication - Labeling (PDF) April 26, 2021
    PDF icon Health Product Risk Communication - Safety (PDF) April 26, 2021
    PDF icon Health Product Risk Communication (PDF) March 5, 2021
    PDF icon Storage, Expiry, Dosing and Administration Guide (PDF) November 2, 2021
    PDF icon Public Advisory - Safety (PDF) November 9, 2021
    PDF icon Health Product Risk Communication - Labeling (PDF) November 18, 2021
    PDF icon Canadian Reference Label
  • Storage, Expiry, Dosage & Administration Guide
  • Patient Immunization Card
  • Vaxcheck Check Vaccine Expiry Date
  • Report an Adverse Drug Reaction

By clicking Continue, I attest that I am a Canadian Healthcare Professional†

†As controlled by respective provincial laws & regulations (e.g., nurse, pharmacist, physician, etc).

Continue

The Canadian Government will oversee the Janssen COVID-19 Vaccine distribution and coordination. Federal and Provincial public health authorities will be responsible for the allocation of doses to populations.

Janssen COVID-19 Vaccine Call Centre

If you have questions about the Janssen COVID-19 Vaccine our call centre healthcare professionals are available anytime at:

1-800-565-4008 (Toll free)

1-908-455-9922

Public Health Agency Of Canada

To monitor vaccine safety, the Public Health Agency of Canada collects information on serious and unexpected reports of adverse events following immunization. Should you wish to report an adverse event following immunization, please complete the Adverse Events Following Immunization (AEFI) Form or call:

1-866-844-0018 (Toll free)

Janssen COVID-19 Vaccine Call Centre

If you wish to report a side effect to Janssen, please call our COVID-19 Vaccine call centre at:

1-800-565-4008 (Toll free)

1-908-455-9922

Janssen

© Janssen Inc. 2021

This site is intended for Healthcare Professionals from Canada only and is published by Janssen Inc., which is solely responsible for its contents. Your use of this information on this site is subject to our Legal Notice. Please see our Privacy Policy. VELCADE® is a trademark of Millennium Pharmaceuticals, Inc.

This site was last modified on: May 5, 2021

Terms and Conditions for Using this Website

By selecting I Accept:

I have read and agree to the Legal Notice and Privacy Policy of this Web site.*

You are a healthcare professional in Canada and that you will only use the information provided on this website as an informational aid for your use only and that you will not disseminate to gain profit from this information.

The information provided to you by Janssen Inc. is not medical advice/recommendations and that the information provided to you is in response to your specific unsolicited request for information.

Janssen Inc. only recommends the use of these products in a manner as described in the Health Canada approved product monograph.

You agree that Janssen Inc., and companies working with Janssen Inc., may passively collect personally identifiable browsing information to customize the site based on your preferences, compile and analyze statistics and trends, and otherwise administer and improve the site for your use.

I do not accept

External Link Page

This link will take you to another website that is unrelated to the Janssen Inc. Medical Information website and to which the Legal Notice and Privacy Policy of the Janssen Inc. Medical Information website do not apply. We encourage you to read the Legal Notice and Privacy Policy of every website you visit. Click the Return button to return to www.janssenmedicalinformation.ca or Continue to continue.

Continue